UAE Artificial Organs & Bionic Implants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The UAE Artificial Organs & Bionic Implants Market is segmented by Product (Artificial Organs and Bionics). The report offers the value (in USD million) for the above segments.

Market Snapshot

CAGR
Study Period: 2019-2027
Base Year: 2021
CAGR: 11.48 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The UAE Artificial Organs & Bionic Implants Market is expected to grow with a CAGR of 11.48% during the forecast period.

The COVID-19 pandemic has impacted the studied market significantly. During the initial phase of the pandemic due to the lockdowns and shutdowns, the number of organ transplants and surgeries decreased to avoid the contamination and spread of coronavirus. However, with resumed services and transplantation procedures, the studied market is expected to witness significant growth over the forecast period.

Certain factors that are propelling the market growth are the increased number of people suffering from organ failures along with the rising incidents of motor accidents and injuries as well as rapid technological advancements in the bionics sector.

The rising number of chronic diseases among the population can lead to organ dysfunction due to lifestyle disorders such as unhealthy dietary habits, smoking, alcohol consumption, and lack of exercise which is the key factor driving the market growth. For instance, according to an article published in July 2020, titled ‘Management of nonalcoholic fatty liver disease in the Middle East’, about 372,000 people were projected to develop Nonalcoholic fatty liver disease (NAFLD) in the United Arab Emirates by 2030. In addition, as per the same source, the prevalence of NAFLD was expected to rise by 87% by 2030 in the UAE.

Additionally, as per a meta-analysis study published in December 2021, titled ‘Prevalence, Awareness, Treatment, and Control of Hypertension in the United Arab Emirates: A Systematic Review and Meta-Analysis’, the combined prevalence of hypertension was 31% in the UAE. In addition, as per the same source, the prevalence of hypertension was highest in Dubai (37%) than in the Abu Dhabi region (29%). Thus, the elevated blood pressure among the population causes the left ventricle to thicken which increases the risk of heart attack, and cardiac failure. This is expected to increase the demand for cardiac bionics, thereby boosting market growth.

Furthermore, as per a news published in October 2021, the team at Cleveland Clinic Abu Dhabi performed two deceased donor kidney transplants and a deceased donor liver transplant, in a single day. In addition, the team completed 10 of the complex transplant procedures in the first three weeks of October. Thus, the rising number of organ transplants in the country is expected to propel the demand for artificial organs and bionics during transplantation procedures, which in turn is anticipated to boost the market growth over the forecast period.

However, the expensive procedure coupled with fear of malfunction or failure of the device is likely to impede the market growth over the forecast period.

Scope of the report

As per the scope of the report, artificial organs and bionics are man-made devices that can be implanted or integrated into humans, to either replace a natural organ or provide support to restore a specific function or a group of related functions, helping the patient to return to his normal life. The UAE Artificial Organs & Bionic Implants Market is segmented by Product (Artificial Organs and Bionics). The report offers the value (in USD million) for the above segments.

By Product
Artificial Organs
Artificial Heart
Artificial Kidney
Cochlear Implants
Others
Bionics
Vision Bionics
Ear Bionics
Orthopedic Bionic
Cardiac Bionics
Others

Report scope can be customized per your requirements. Click here.

Key Market Trends

Artificial Kidney Segment is Expected to Have a Highest Growth Rate in the UAE Artificial Organs and Bionic Implants Market Over the Forecast Period

The artificial kidney segment is expected to witness significant growth in the artificial organs and bionic implants market over the forecast period owing to the factors such as the rising prevalence of renal failures as well as increasing chronic diseases such as diabetes that lead to kidney disease.

A wearable artificial kidney is a wearable dialysis machine. An individual with end-stage renal disease may use a wearable artificial kidney on a daily or even a continuous basis. The increasing incidence and prevalence of renal failures in India are expected to drive segment growth.

Kidney failure or dysfunction has become a burden in the country recently. For instance, according to an article published in February 2021, titled ‘Kidney Dysfunction among COVID-19 Patients in the United Arab Emirates’, it has been observed that renal impairment in COVID-19 individuals ranged from mild to severe. In addition, as per the same source, the most prevalent underlying conditions linked with moderate-to-severe renal function impairment among COVID-19 patients were diabetes mellitus and hypertension.

Additionally, according to the 2022 statistics published by the International Diabetes Federation Diabetes Atlas 10thedition of 2021, in the United Arab Emirates, 990.9 thousand people were living with diabetes, in 2021. In addition, as per the same source, this number is projected to reach 1,177.5 thousand by 2030. Thus, the high blood sugar from diabetes can damage blood vessels in the kidney as well as nephrons leading to kidney disease and kidney failure. This is expected to increase the demand for organ transplantation which in turn is anticipated to propel the market growth over the forecast period.

Therefore, owing to the aforesaid factors the segment is expected to witness growth over the forecast period.

123

Competitive Landscape

The UAE Artificial Organs & Bionic Implants Market is moderately competitive with several major players. Some of the strategies implemented include agreements, collaborative models, business expansion, and product developments. Some of the major companies of the country are, Boston Scientific Corporation, Medtronic plc, Otto Bock Holding GmbH & Co. KG, Zimmer Biomet, etc.

Recent Development

  • In March 2022, the Dubai Health Authority launched an awareness campaign on World Kidney Day to encourage people to voluntarily register their organ donation decision and raise awareness about how organ donation can dramatically improve the health of patients with organ failure, and in some instances save their lives.
  • In January 2022, the Abu Dhabi Health Services Company (Seha) implanted an Implantable Cardioverter Defibrillator (ICD) in a seven-year-old boy.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Number of People Suffering from Organ Failures and Rising Incidents of Motor Accidents and Injuries

      2. 4.2.2 Rapid technological advancements in the bionics sector

    3. 4.3 Market Restraints

      1. 4.3.1 Expensive Procedures Coupled with Fear of Malfunction or Failure of Device

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product

      1. 5.1.1 Artificial Organs

        1. 5.1.1.1 Artificial Heart

        2. 5.1.1.2 Artificial Kidney

        3. 5.1.1.3 Cochlear Implants

        4. 5.1.1.4 Others

      2. 5.1.2 Bionics

        1. 5.1.2.1 Vision Bionics

        2. 5.1.2.2 Ear Bionics

        3. 5.1.2.3 Orthopedic Bionic

        4. 5.1.2.4 Cardiac Bionics

        5. 5.1.2.5 Others

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Otto Bock Holding GmbH & Co. KG

      3. 6.1.3 Medtronic plc

      4. 6.1.4 Zimmer Biomet

      5. 6.1.5 Edwards Lifesciences Corporation

      6. 6.1.6 Abbott Laboratories (ST. JUDE MEDICAL, INC.)

      7. 6.1.7 Edrees Medical

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The UAE Artificial Organs & Bionic Implants Market market is studied from 2019 - 2027.

The UAE Artificial Organs & Bionic Implants Market is growing at a CAGR of 11.48% over the next 5 years.

Boston Scientific Corporation, Medtronic plc, Edwards Lifesciences Corporation, Zimmer Biomet, Otto Bock Holding GmbH & Co. KG are the major companies operating in UAE Artificial Organs & Bionic Implants Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!